Four out of five Americans will experience back pain in their lifetime. It is the most common reason employees miss work and is costly to manage, approximately US$200 billion annually.
But the billions of dollars spent on treatment may not be worth the growing evidence that pain-killing interventions are not as effective as they have long been thought.
Large Meta-Analysis Study of Back Pain and Pharmacotherapy Reveals Persistent Popularity of Drugs to Treat Acute Diseases, Yet It’s Not Clear How Effective They Actually Are became.
Researchers at Neuroscience Research Australia (NeuRA), the University of New South Wales (UNSW), and Brunel University London conducted a study of 98 trials involving 15,134 adults with nonspecific acute low back pain between 1964 and 2021. randomized controlled trials were investigated. They examined 69 different pain relievers, including nonsteroidal anti-inflammatory drugs, acetaminophen/paracetamol, opioids, anticonvulsants, antidepressants, skeletal muscle relaxants, and corticosteroids.
The most comprehensive study of its kind reveals a lack of conclusive evidence that pain relievers are more effective than placebos, and an ever-increasing lack of medical research into efficacy.
Dr Neil O’Connell, Brunel University London, said: “The evidence on the efficacy and safety of some of the most commonly used drugs for these common conditions is very weak and incomplete. One thing is quite shocking: “Our findings underscore the need for larger, more rigorous trials that can truly inform better clinical decisions.”
This study highlights the complexity of treating back pain and how some drugs, such as opioids, can cause significant side effects. are prescribed opioids for back pain.
“Despite more than 60 years of research, it is still unclear whether pain relievers provide meaningful pain relief for people with low back pain,” said NeuRA’s James McAuley, who is also a professor in the UNSW School of Health Sciences. “Physicians and patients are advised to take a cautious approach to the management of acute low back pain with analgesics until better quality trials are available for head-to-head comparisons.”
These findings revealed that anti-inflammatory drugs may increase the risk of chronic pain by blocking first responder immune cells, neutrophils, and prolonging recovery, McGill said last year. This is a follow-up to university research.
Acute low back pain, a condition lasting up to 6 weeks, is one of the main reasons people seek medical attention. Guidelines now recommend superficial heat, massage, acupuncture, spinal manipulation, or other physical activities as first-line treatments.
“Patients should be reassured that acute low back pain is very likely to resolve on its own over time, regardless of whether medication is taken.” should take a cautious approach and, importantly, consult with the patient about their specific pain experience, severity of symptoms, and individual needs and preferences before making this decision. Our research shows.”
A study was published in a journal BMJMore.
Source: University of New South Wales
